[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f1uAS9-OaMEknc6vWC7Ki0OhHocRjwFSRf8Mlo1THVn0":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":9,"nonDrugCount":11,"topConditions":12,"upcomingReadouts":31,"phaseBuckets":37,"rows":44},"Children's Healthcare of Atlanta",[4],95,false,3,1,13729,90,[13,16,18,21,23,25,27,29],{"name":14,"count":15},"Congenital Disorders",49,{"name":17,"count":8},"Critical Illness",{"name":19,"count":20},"Congenital Heart Disease",2,{"name":22,"count":20},"Congenital Heart Defects",{"name":24,"count":20},"Pain",{"name":26,"count":20},"Burnout",{"name":28,"count":9},"Respiratory Syncytial Virus Infections",{"name":30,"count":9},"Pediatric Preoperative Anxiety, Pediatric Coping",[32],{"nctId":33,"briefTitle":34,"date":35,"intervention":36},"NCT03625011","Gabapentin Premedication to Reduce Postoperative Pain for Pediatric Tonsillectomy","2019-12-31","Gabapentin",[38,39,40,41,42,43],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[45,69,97,115,141,168,186],{"intervention":36,"totalTrials":9,"cells":46},{"EARLY_PHASE1":47,"PHASE1":50,"PHASE2":52,"PHASE3":54,"PHASE4":56,"NA":67},{"trials":48,"activeCount":49},[],0,{"trials":51,"activeCount":49},[],{"trials":53,"activeCount":49},[],{"trials":55,"activeCount":49},[],{"trials":57,"activeCount":9,"soonestReadout":35},[58],{"nctId":33,"briefTitle":34,"status":59,"phases":60,"primaryCompletion":35,"completion":35,"start":61,"enrollment":62,"conditions":63,"interventions":66},"RECRUITING",[42],"2018-07-31",50,[64,65],"Tonsillitis","Tonsillectomy",[36],{"trials":68,"activeCount":49},[],{"intervention":70,"totalTrials":9,"cells":71},"Morphine",{"EARLY_PHASE1":72,"PHASE1":74,"PHASE2":76,"PHASE3":78,"PHASE4":93,"NA":95},{"trials":73,"activeCount":49},[],{"trials":75,"activeCount":49},[],{"trials":77,"activeCount":49},[],{"trials":79,"activeCount":49},[80],{"nctId":81,"briefTitle":82,"status":83,"phases":84,"primaryCompletion":85,"completion":86,"start":87,"enrollment":88,"conditions":89,"interventions":91},"NCT01380197","Choosing Opioid Management for Pain and Analyzing Acute Chest Syndrome (ACS) Rates Equally","COMPLETED",[41],"2014-01-14","2016-10-18","2010-05-26",40,[24,90],"Sickle Cell Disease",[70,92],"Nubain",{"trials":94,"activeCount":49},[],{"trials":96,"activeCount":49},[],{"intervention":92,"totalTrials":9,"cells":98},{"EARLY_PHASE1":99,"PHASE1":101,"PHASE2":103,"PHASE3":105,"PHASE4":111,"NA":113},{"trials":100,"activeCount":49},[],{"trials":102,"activeCount":49},[],{"trials":104,"activeCount":49},[],{"trials":106,"activeCount":49},[107],{"nctId":81,"briefTitle":82,"status":83,"phases":108,"primaryCompletion":85,"completion":86,"start":87,"enrollment":88,"conditions":109,"interventions":110},[41],[24,90],[70,92],{"trials":112,"activeCount":49},[],{"trials":114,"activeCount":49},[],{"intervention":116,"totalTrials":9,"cells":117},"Ethanol Lock",{"EARLY_PHASE1":118,"PHASE1":120,"PHASE2":133,"PHASE3":135,"PHASE4":137,"NA":139},{"trials":119,"activeCount":49},[],{"trials":121,"activeCount":49},[122],{"nctId":123,"briefTitle":124,"status":83,"phases":125,"primaryCompletion":126,"completion":127,"start":128,"enrollment":129,"conditions":130,"interventions":132},"NCT01865708","Pilot Study of the Safety of a Daily Ethanol Lock for Urinary Catheters in Critically Ill Children",[39],"2013-11","2015-06","2013-07",10,[131],"Complication of Urinary Catheter",[116],{"trials":134,"activeCount":49},[],{"trials":136,"activeCount":49},[],{"trials":138,"activeCount":49},[],{"trials":140,"activeCount":49},[],{"intervention":142,"totalTrials":9,"cells":143},"Propofol",{"EARLY_PHASE1":144,"PHASE1":146,"PHASE2":148,"PHASE3":150,"PHASE4":152,"NA":154},{"trials":145,"activeCount":49},[],{"trials":147,"activeCount":49},[],{"trials":149,"activeCount":49},[],{"trials":151,"activeCount":49},[],{"trials":153,"activeCount":49},[],{"trials":155,"activeCount":49},[156],{"nctId":157,"briefTitle":158,"status":159,"phases":160,"primaryCompletion":161,"completion":161,"start":162,"enrollment":163,"conditions":164,"interventions":166},"NCT03552146","Evaluating the Effects of Propofol vs. Dexmedetomidine","UNKNOWN",[],"2019-09-30","2018-07-24",60,[165],"Sedative Adverse Reaction",[142,167],"Dexmedetomidine",{"intervention":167,"totalTrials":9,"cells":169},{"EARLY_PHASE1":170,"PHASE1":172,"PHASE2":174,"PHASE3":176,"PHASE4":178,"NA":180},{"trials":171,"activeCount":49},[],{"trials":173,"activeCount":49},[],{"trials":175,"activeCount":49},[],{"trials":177,"activeCount":49},[],{"trials":179,"activeCount":49},[],{"trials":181,"activeCount":49},[182],{"nctId":157,"briefTitle":158,"status":159,"phases":183,"primaryCompletion":161,"completion":161,"start":162,"enrollment":163,"conditions":184,"interventions":185},[],[165],[142,167],{"intervention":187,"totalTrials":9,"cells":188},"Lidocaine Lubricant",{"EARLY_PHASE1":189,"PHASE1":191,"PHASE2":193,"PHASE3":195,"PHASE4":197,"NA":199},{"trials":190,"activeCount":49},[],{"trials":192,"activeCount":49},[],{"trials":194,"activeCount":49},[],{"trials":196,"activeCount":49},[],{"trials":198,"activeCount":49},[],{"trials":200,"activeCount":49},[201],{"nctId":202,"briefTitle":203,"status":83,"phases":204,"completion":205,"start":206,"enrollment":207,"conditions":208,"interventions":210},"NCT00596375","Lidocaine Lubricant in Pediatric Urethral Catheterization",[43],"2007-03","2006-08",47,[209,24],"Fevers",[187]]